Venom Peptides as Precision Therapeutics: From Discovery to Clinical Translation

A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Animal Venoms".

Deadline for manuscript submissions: 30 November 2026 | Viewed by 297

Editors


E-Mail Website
Guest Editor
1. Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Avenida de Universidade, Taipa, Macau SAR 999078, China
2. Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Avenida de Universidade, Taipa, Macau SAR 999078, China
Interests: novel therapeutic antibody development; venom-based peptide and natural biomolecule prototype drug development; cancer biomarker and immunotherapy marker discovery for prognostic and therapeutic validation
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Biochemistry, Paulista School of Medicine, Federal University of São Paulo, São Paulo 04023-062, Brazil
Interests: mass spectrometry; peptidomics; proteomics; toxins; antibodies; de novo sequencing

Special Issue Information

Dear Colleagues,

This Special Issue titled, "Venom Peptides as Precision Therapeutics: From Discovery to Clinical Translation", explores the potential of venom-derived peptides in modern therapeutics. Venoms from various organisms, including snakes, spiders, and marine life, are rich sources of bioactive compounds with unique pharmacological properties. This Special Issue will focus on the multifaceted journey of venom peptides, from their initial discovery and characterization to their application as targeted therapies in clinical settings.

We will explore the biochemical mechanisms of action, the innovative techniques used in peptide synthesis and modification, and advancements in drug formulation. Furthermore, this Special Issue will highlight recent breakthroughs in the clinical translation of venom peptides, showcasing case studies where these compounds have successfully been developed into effective treatments for conditions such as cancer, pain management, and autoimmune diseases.

By bringing together contributions from leading researchers in the field, our goal is to foster a comprehensive understanding of the therapeutic potential of venom peptides while addressing the challenges of their development. This Special Issue will serve as an invaluable resource for researchers, clinicians, and pharmaceutical developers interested in the intersection of natural products and precision medicine.

Prof. Dr. Hang Fai (Henry) Kwok
Dr. Alexandre K. Tashima
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • venom peptides
  • precision therapeutics
  • drug development
  • clinical translation
  • pharmacology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop